- CH₣14.68bn
- CH₣14.75bn
- CH₣885.32m
2019 December 31st | R2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 570 | 692 | 901 | 1,145 | 885 |
Cost of Revenue | |||||
Gross Profit | 345 | 430 | 570 | 734 | 547 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 463 | 523 | 636 | 786 | 657 |
Operating Profit | 108 | 170 | 265 | 359 | 229 |
Total Net Non Operating Interest Income / Expense | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 99 | 154 | 258 | 356 | 207 |
Provision for Income Taxes | |||||
Net Income After Taxes | 74.8 | 128 | 217 | 307 | 190 |
Net Income Before Extraordinary Items | |||||
Net Income | 74.8 | 128 | 217 | 307 | 190 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 74.8 | 128 | 217 | 307 | 190 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 2.5 | 4.27 | 7.32 | 10.2 | 6.37 |
Dividends per Share |